Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Scientific Advisory Board

    - PMLiVE

    TRIMTECH Therapeutics appoints Alison Lawton as Chair of the Board

    Lawton previously held senior positions at Genzyme, Kaleido and Aura Biosciences

    - PMLiVE

    TRIMTECH Therapeutics establishes Scientific Advisory Board

    Alessio Ciulli has been appointed as Chair of the board

    - PMLiVE

    Roche shares promising data from Alzheimer’s disease development portfolio

    The company is planning to initiate phase 3 studies of trontinemab in early AD this year

    - PMLiVE

    UKDRI researchers to evaluate new blood test for neurodegenerative disease diagnosis

    It is hoped that the test could be available for widespread UK use in the coming years

    - PMLiVE

    GSK and ABL Bio enter neurodegenerative disease agreement worth over £2bn

    The licensing deal will give GSK access to ABL Bio's blood-brain barrier shuttle platform

    - PMLiVE

    Sanofi’s investigational MS treatment tolebrutinib granted FDA priority review

    Approximately 2.9 million people worldwide are living with the neurodegenerative disease

    - PMLiVE

    GSK to explore link between Shingrix and dementia risk in new UK research collaboration

    More than 55 million people worldwide are currently living with the neurodegenerative disease

    - PMLiVE

    UK drug repurposing study identifies several potential dementia treatments

    An estimated 982,000 people in the UK are currently living with the neurodegenerative disease

    - PMLiVE

    Eli Lilly and Alchemab Therapeutics partner to develop new ALS therapies

    The neurodegenerative disease affects approximately 30,000 people in the US

    - PMLiVE

    Researchers develop new approach to target cells affected by motor neurone disease

    The technique could lead to safer and more effective gene therapies for the neurodegenerative disease

    - PMLiVE

    Mayo Clinic explores AI and brain waves for neurodegenerative disease diagnosis

    The team is using AI to assist in analysing routine EEGs for early identification of brain disorders

    - PMLiVE

    Roche’s Genentech and Sangamo enter neurodegenerative disease partnership worth over $1.9bn

    According to WHO, neurological conditions are now the leading cause of ill health and disability worldwide

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links